BACKGROUND: To promote clinical application of the Schedules for Clinical Assessment in Neuropsychiatry (SCAN) system a shorter version (the mini-SCAN) was devised. Its psychometric properties were unknown. AIMS: To establish the validity and practical properties of the mini-SCAN. METHOD: One hundred and six participants were interviewed twice, once with the SCAN and once with the mini-SCAN. The level of agreement was established for the categories: no disorder, affective disorders, anxiety disorders, non-affective psychotic disorders, affective psychotic disorders. RESULTS: The mini-SCAN is a valid instrument. Most kappa values were around 0.90. Only for the class of affective psychotic disorders was the agreement moderate. Mean duration of the mini-SCAN interviews was 25 min shorter than the SCAN interviews. Participants and interviewers were generally satisfied with the interview format and questions. CONCLUSIONS: The mini-SCAN can be used as a diagnostic instrument for clinical purposes and for clinical studies when the present episode is the focus of attention.
BACKGROUND: To promote clinical application of the Schedules for Clinical Assessment in Neuropsychiatry (SCAN) system a shorter version (the mini-SCAN) was devised. Its psychometric properties were unknown. AIMS: To establish the validity and practical properties of the mini-SCAN. METHOD: One hundred and six participants were interviewed twice, once with the SCAN and once with the mini-SCAN. The level of agreement was established for the categories: no disorder, affective disorders, anxiety disorders, non-affective psychotic disorders, affective psychotic disorders. RESULTS: The mini-SCAN is a valid instrument. Most kappa values were around 0.90. Only for the class of affective psychotic disorders was the agreement moderate. Mean duration of the mini-SCAN interviews was 25 min shorter than the SCAN interviews. Participants and interviewers were generally satisfied with the interview format and questions. CONCLUSIONS: The mini-SCAN can be used as a diagnostic instrument for clinical purposes and for clinical studies when the present episode is the focus of attention.
Authors: Ahmed Aboraya; Henry Nasrallah; Srinivas Muvvala; Ahmed El-Missiry; Hader Mansour; Cheryl Hill; Daniel Elswick; Elizabeth C Price Journal: Innov Clin Neurosci Date: 2016-06-01
Authors: Max de Leeuw; Marc M Bohlken; René Cw Mandl; Manon Hj Hillegers; René S Kahn; Matthijs Vink Journal: Neuropsychopharmacology Date: 2016-07-21 Impact factor: 7.853
Authors: Eva Velthorst; Abraham Reichenberg; Jonathan Rabinowitz; Stephen Z Levine Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2015-10-13 Impact factor: 4.328
Authors: Sanne H Booij; Marieke Wichers; Peter de Jonge; Sjoerd Sytema; Jim van Os; Lex Wunderink; Johanna T W Wigman Journal: BMJ Open Date: 2018-01-21 Impact factor: 2.692
Authors: Marieke J Schreuder; Robin N Groen; Johanna T W Wigman; Catharina A Hartman; Marieke Wichers Journal: BMC Psychiatry Date: 2020-07-06 Impact factor: 3.630
Authors: Johanna T W Wigman; Gerdina H M Pijnenborg; Richard Bruggeman; Maarten Vos; Anita Wessels; Inez Oosterholt; Maaike Nauta; Renee Stelwagen; Lana Otto; Anniek Wester; Lex Wunderink; Esther Sportel; Nynke Boonstra Journal: Early Interv Psychiatry Date: 2019-11-05 Impact factor: 2.732